Peter Attia· MD
in that trial apoe4 carriers had zero response and non-carriers appeared to improve on the primary outcome the adas cog and on the secondary outcome which is the mmsc
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in that trial apoe4 carriers had zero response and non-carriers appeared to improve on the primary outcome the adas cog and on the secondary outcome which is the mmsc
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
in this trial two grams of omega-3s had no effect on everyone zero effect the trial was negative was published in 2010 in java